![Chad Decker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chad Decker active positions
Companies | Position | Start | End |
---|---|---|---|
Alphazyme LLC
![]() Alphazyme LLC Miscellaneous Commercial ServicesCommercial Services Part of Maravai Lifesciences Holdings, Inc., Alphazyme LLC is a company that specializes in the development and production of custom molecular biology enzymes at an industrial scale. The company is based in Jupiter, FL. The company collaborates with manufacturers of nucleic acid synthesis and detection platforms to produce high-quality and affordable enzymes for the growing markets of custom DNA and RNA molecules, genomic medicines, and genetic analysis. Alphazyme's mission is to be the world's premier partner for industrial-scale molecular biology enzymes. The company was founded by Christopher Benoit, who has been the CEO since incorporation. Alphazyme was acquired by Maravai Lifesciences Holdings, Inc. on February 22, 2023, for $145 million. | Chief Operating Officer | - | - |
Career history of Chad Decker
Statistics
International
United States | 2 |
Operational
Chief Operating Officer | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Alphazyme LLC
![]() Alphazyme LLC Miscellaneous Commercial ServicesCommercial Services Part of Maravai Lifesciences Holdings, Inc., Alphazyme LLC is a company that specializes in the development and production of custom molecular biology enzymes at an industrial scale. The company is based in Jupiter, FL. The company collaborates with manufacturers of nucleic acid synthesis and detection platforms to produce high-quality and affordable enzymes for the growing markets of custom DNA and RNA molecules, genomic medicines, and genetic analysis. Alphazyme's mission is to be the world's premier partner for industrial-scale molecular biology enzymes. The company was founded by Christopher Benoit, who has been the CEO since incorporation. Alphazyme was acquired by Maravai Lifesciences Holdings, Inc. on February 22, 2023, for $145 million. | Commercial Services |
- Stock Market
- Insiders
- Chad Decker
- Experience